[Risk on bias assessment: (6) A Revised Tool for the Quality Assessment on Diagnostic Accuracy Studies (QUADAS-2)]
- PMID: 29699051
- DOI: 10.3760/cma.j.issn.0254-6450.2018.04.028
[Risk on bias assessment: (6) A Revised Tool for the Quality Assessment on Diagnostic Accuracy Studies (QUADAS-2)]
Abstract
This paper introduced the Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2), including the development and comparison with the original QUADAS, and illustrated the application of QUADAS-2 in a published paper related to the study on diagnostic accuracy which was included in systematic review and Meta-analysis. QUADAS-2 presented considerable improvement over the original tool. Confused items that included in QUADAS had disappeared and the quality assessment of the original study replaced by the rating of risk on bias and applicability. This was implemented through the description on the four main domains with minimal overlapping and answering the signal questions in each domain. The risk of bias and applicability with 'high','low' or 'unclear' was in line with the risk of bias assessment of intervention studies in Cochrane, so to replace the total score of quality assessment in QUADAS. Meanwhile, QUADAS-2 was also applicable to assess the diagnostic accuracy studies in which follow-up without prognosis was involved in golden standard. It was useful to assess the overall methodological quality of the study despite more time consuming than the original QUADAS. However, QUADAS-2 needs to be modified to apply in comparative studies on diagnostic accuracy and we hope the users would follow the updates and give their feedbacks on line.
本讲座详细介绍了诊断试验准确性研究的偏倚评估工具(QUADAS-2)的主要内容,同时阐述了QUADAS-2的开发过程及与第一版QUADAS工具的区别,并举例说明QUADAS-2的使用方法和注意事项。QUADAS-2相比第一版QUADAS工具有巨大改进,例如QUADAS-2删除了QUADAS中易混淆的条目内容,仅通过对重叠度最小的4个关键领域(Domain)的描述和对每个领域内信号问题的回答完成偏倚风险和适用性两个核心方面的评价,最后得出原始研究每个领域的偏倚风险和适用性为高(High)、低(Low)或不清楚(Unclear)的结论,而不再是给出原始研究质量评价的总分,这与Cochrane干预措施系统综述中偏倚风险的评估一致。同时,QUADAS-2还可以应用于金标准中包括随访但不涉及预后问题的原始研究的偏倚风险评价。虽然开展QUADAS-2评价需要花费更多时间,但这对于诊断准确性研究的偏倚风险评价非常重要。QUADAS-2研究组后续还将在比较多种待评价诊断试验的原始研究中应用QUADAS-2进行偏倚风险评估,使用者可持续关注其进展,同时也可在线反馈使用体验或提供改进建议。.
Keywords: Diagnostic accuracy studies; Risk of bias; Systematic review; Tool for assessment.
Similar articles
-
Quality assessment of comparative diagnostic accuracy studies: our experience using a modified version of the QUADAS-2 tool.Res Synth Methods. 2013 Sep;4(3):280-6. doi: 10.1002/jrsm.1080. Epub 2013 Jun 10. Res Synth Methods. 2013. PMID: 26053845
-
[QUADAS-C-A tool for assessing risk of bias regarding Quality Assessment of Diagnostic Accuracy Studies-Comparative].Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Jun 10;43(6):938-944. doi: 10.3760/cma.j.cn112338-20211101-00841. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. PMID: 35725353 Chinese.
-
Development and validation of methods for assessing the quality of diagnostic accuracy studies.Health Technol Assess. 2004 Jun;8(25):iii, 1-234. doi: 10.3310/hta8250. Health Technol Assess. 2004. PMID: 15193208 Review.
-
QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies.Ann Intern Med. 2021 Nov;174(11):1592-1599. doi: 10.7326/M21-2234. Epub 2021 Oct 26. Ann Intern Med. 2021. PMID: 34698503
-
QUAPAS: An Adaptation of the QUADAS-2 Tool to Assess Prognostic Accuracy Studies.Ann Intern Med. 2022 Jul;175(7):1010-1018. doi: 10.7326/M22-0276. Epub 2022 Jun 14. Ann Intern Med. 2022. PMID: 35696685
Cited by
-
Meta-analysis of machine learning models for the diagnosis of central precocious puberty based on clinical, hormonal (laboratory) and imaging data.Front Endocrinol (Lausanne). 2024 Mar 25;15:1353023. doi: 10.3389/fendo.2024.1353023. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38590824 Free PMC article.
-
Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023).Pediatr Investig. 2025 Mar 11;9(1):1-11. doi: 10.1002/ped4.12469. eCollection 2025 Mar. Pediatr Investig. 2025. PMID: 40241891 Free PMC article.
-
Diagnostic accuracy of transthoracic echocardiography for acute type A aortic syndrome: A systematic review and meta-analysis.Biomed J. 2025 Apr;48(2):100747. doi: 10.1016/j.bj.2024.100747. Epub 2024 May 10. Biomed J. 2025. PMID: 38735535 Free PMC article.
-
A PRISMA meta-analysis for diagnostic value of microRNA-21 in head and neck squamous cell carcinoma along with bioinformatics research.Oral Maxillofac Surg. 2024 Jun;28(2):739-752. doi: 10.1007/s10006-023-01199-7. Epub 2023 Dec 1. Oral Maxillofac Surg. 2024. PMID: 38038839
-
Advances in analytical approaches for background parenchymal enhancement in predicting breast tumor response to neoadjuvant chemotherapy: A systematic review.PLoS One. 2025 Mar 7;20(3):e0317240. doi: 10.1371/journal.pone.0317240. eCollection 2025. PLoS One. 2025. PMID: 40053513 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical